Ferroxidases and xanthine oxidase in plasma of healthy newborn infants

References

• Gutteridge J.M., Rowley D.A., Griffiths E., Halliwell B. Low-molecular weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin. Sci. 1985; 68: 463–467
   PubMed Web of Science ®Google Scholar
• Gutteridge J.M.C., Rowley D.A., Halliwell B. Superoxide dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron-salts. Detection of “catalytic” iron and anti-oxidant activity in extracellular fluids. Biochem. J. 1982; 206: 605–609
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. Oxford University Press, Oxford 1989
   Google Scholar
• Repine J.E. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992; 339: 466–469
   PubMed Web of Science ®Google Scholar
• Evans P.J., Evans R., Kovar I.Z., Holton A.F., Halliwell B. Bleomycin-detectable iron in the plasma of premature and full-term infants. FEBS Lett. 1992; 303: 210–212
   PubMed Web of Science ®Google Scholar
• Moison R.M.W., Palinckx J.J.S., Roest M., Houdkamp E., Berger H.M. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993; 341: 79–82
   PubMed Web of Science ®Google Scholar
• Osaki S., Johnson D.A., Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human sera. J. Biol. Chem. 1966; 241: 2746–2751
   PubMed Web of Science ®Google Scholar
• Gutteridge J.M.C. Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation. FEBS Lett. 1983; 157: 37–40
   PubMed Web of Science ®Google Scholar
• Chidambaram M.V., Barnes G., Frieden E. Ceruloplasmin and the reaction forming diferric transferrin. FEBS Lett. 1983; 159: 137–140
   PubMedGoogle Scholar
• Richardson D.R., Ponka P. The molecular mechanism of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1997; 1331: 1–40
   PubMed Web of Science ®Google Scholar
• Osaki S., Johnson D.A., Frieden E. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J. Biol. Chem. 1971; 246: 3018–3023
   PubMed Web of Science ®Google Scholar
• Harris Z.L., Durley A.P., Man T.K., Gitlin J.D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. USA 1999; 96: 10812–10817
   PubMed Web of Science ®Google Scholar
• Topham R.W., Frieden E. Identification and purification of a non-ceruloplasmin ferroxidase of human serum. J. Biol. Chem. 1970; 245: 6698–6705
   PubMed Web of Science ®Google Scholar
• Winyard P.G., Arundell L.A., Drake D.R. Lipoprotein oxidation and induction of ferroxidase activity in stored human extracellular fluids. Free Rad. Res. Commun. 1989; 5: 227–235
   PubMed Web of Science ®Google Scholar
• Topham R.W., Johnson D.A. Studies of the ferroxidase activity of native and chemically modified xanthine oxidoreductase. Biochem. J. 1986; 235: 39–44
   PubMedGoogle Scholar
• Hall-Sizemore A., Joseph J.J., Topham R.W. Xanthine oxidase: an efficient promoter of iron loading of apoferritin. Biochem. Mol. Biol. Int. 1994; 33: 393–403
   PubMedGoogle Scholar
• Mora F., Quesada T., Pena J., Osario C. Immunological and oxidase measurement of ceruloplasmin in pregnant women and newborn. Rev. Esp. Fisiol. 1976; 32: 103–106
   PubMedGoogle Scholar
• Lindeman J.H.N., Lentjes E.G.W.M., van Zoeren-Grobben D., Berger H.M. Postnatal changes in plasma ceruloplasmin and transferrin antioxidant activities in preterm babies. Biol. Neonate 2000; 78: 73–76
   PubMedGoogle Scholar
• Koo W.W.K., Succop P., Hambidge K.M. Sequential concentrations of copper and ceruloplasmin in serum from preterm infants with rickets and fractures. Clin. Chem. 1991; 37: 556–559
   PubMed Web of Science ®Google Scholar
• Kanakoudi F., Drossou V., Tzimouli V., Diamanti E., Konstantinidis T., Germenis A., Kremenopoulos G. Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. Clin. Chem. 1995; 41: 605–608
   PubMed Web of Science ®Google Scholar
• Tan S., Radi R., Gaudier F., Evans R.A., Rivera A., Kirk K.A., Parks D.A. Physiologic levels of uric acid inhibit xanthine oxidase. Pediat. Res. 1993; 34: 303–307
   PubMed Web of Science ®Google Scholar
• Boda D., Nemeth I., Hencz P., Denes K. Effect of allopurinol treatment in premature infants with idiopathic respiratory distress syndrome. Dev. Pharmacol. Ther. 1984; 7: 357–367
   PubMedGoogle Scholar
• Russell G.A.B., Cooke R.W.I. Randomized controlled trial of allopurinol prophylaxis in very preterm infants. Arch. Dis. Child. 1995; 73: F27–F31
   Google Scholar
• van Bel F., Shadid M., Moison R.M.W., Dorrepaal C.A., Fontijn J., Monteiro L., van De Bor M., Berger H.M. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998; 101: 185–193
   PubMed Web of Science ®Google Scholar
• Johnson D.A., Osaki S., Frieden E. A micromethod for the determination of ferroxidase (ceruloplasmin) in human serum. Clin. Chem. 1967; 13: 142–150
   PubMed Web of Science ®Google Scholar
• Ramboer C.H. A sensitive and nonradioactive assay for serum and tissue xanthine oxidase. J. Lab. Clin. Med. 1969; 74: 828–835
   PubMedGoogle Scholar
• Terada L.S., Willingham I.R., Rosandich M.E., Leff J.A., Kindt G.W., Repine J.E. Generation of superoxide anion by brain endothelial cell xanthine oxidase. J. Cell. Physiol. 1991; 148: 191–196
   PubMed Web of Science ®Google Scholar
• Swain J.A., Darley-Usmar V., Gutteridge J.M. Peroxinitrite releases copper from ceruloplasmin: implications for atherosclerosis. FEBS Lett 1994; 342: 49–52
   PubMed Web of Science ®Google Scholar
• Erel O. Automated measurement of serum ferroxidase activity. Clin. Chem. 1998; 44: 2313–2319
   PubMed Web of Science ®Google Scholar
• Airede A.I. Serial copper and ceruloplasmin levels in African newborns with emphasis on the sick and stable preterm infant, and their antioxidant capacities. Early Hum. Dev. 1998; 52: 199–210
   PubMedGoogle Scholar
• Montagna O., Grosso R., Santoro A., Mautone A. Plasma levels of the serum antioxidants (uric acid, ceruloplasmin, transferrin) in term and preterm neonates in the first week of life. Minerva Pediatrica 1994; 46: 255–260
   PubMedGoogle Scholar
• Suri M., Sharma V.K., Thirupuram S. Evaluation of ceruloplasmin in neonatal septicemia. Indian Pediat 1991; 28: 489–493
   PubMedGoogle Scholar
• Perlman M., Chan W.Y., Ramadan T.Z., McCaffree M.A., Rennert O.M. Serum copper and ceruloplasmin in preterm infants. J. Am. Coll. Nutrit. 1982; 1: 155–163
   PubMedGoogle Scholar
• Powers H.J., Loban A., Silvers K., Gibson A.T. Vitamin C at concentrations observed in premature babies inhibits the ferroxidase activity of caeruloplasmin. Free Rad. Res. 1995; 22: 57–65
   PubMed Web of Science ®Google Scholar
• Berger T.M., Polidori M.C., Dabbagh A., Evans P.J., Halliwell B., Morrow J.D., Roberts L.J., Frei B. Antioxidant activity of vitamin C in iron-overloaded human plasma. J. Biol. Chem. 1997; 272: 15656–15660
   PubMed Web of Science ®Google Scholar
• Lovstad R.A. A study on ascorbate inhibition of ceruloplasmin ferroxidase activity. Biometals 1997; 10: 123–126
   PubMedGoogle Scholar
• Saugstad O.D. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediat. Res. 1988; 23: 143–150
   PubMed Web of Science ®Google Scholar
• Swain J., Gutteridge J.M. Gutteridge Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett. 1995; 368: 513–515
   PubMed Web of Science ®Google Scholar
• Lacy F., Gough D.A., Schmid-Schonbein G.W. Role of xanthine oxidase in hydrogen peroxide production. Free Rad. Biol. Med. 1998; 25: 720–727
   PubMed Web of Science ®Google Scholar
• Houston M., Estevez A., Chumley P., Aslan M., Marklund S., Parks D.A., Freeman B.A. Binding of xanthine oxidase to vascular endothelium. J. Biol. Chem. 1999; 274: 4985–4994
   PubMed Web of Science ®Google Scholar
• Friedl H.P., Smith D.J., Till G.O., Thomson P.D., Louis D.S., Ward P.A. Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity. Am. J. Pathol. 1990; 136: 491–495
   PubMed Web of Science ®Google Scholar
• Karg E., Nemeth I., Virag G., Meszaros T., Boda D., Pinter S. Oxidative stress induced by bloodless limb surgery on humans. Eur. J. Clin. Invest. 1997; 27: 984–991
   PubMedGoogle Scholar
• Supnet M.C., David-Cu R., Walther F.J. Plasma xanthine oxidase activity and infant hydroperoxide levels in preterm infants. Pediat. Res. 1994; 36: 283–287
   PubMedGoogle Scholar
• Tan S., Yokoyama Y., Dickens E., Cash T.G., Parks B.A. Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Rad. Biol. Med. 1993; 15: 407–414
   PubMed Web of Science ®Google Scholar
• Adachi T., Fukushima T., Usami Y., Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem. J. 1993; 289: 523–527
   PubMed Web of Science ®Google Scholar
• Petrone W.F., English D.K., Wong K., McCord J.M. Free radicals and inflammation: the superoxide dependent activation of neutrophil chemotactic factor in plasma. Proc. Natl. Acad. Sci. USA 1980; 77: 1159–1163
   PubMed Web of Science ®Google Scholar
• White C.R., Darley-Usmar V., Berrington W.R., McAdams M., Gore J.Z., Thompson J.A., Parks D.A., Tarpey M.M., Freeman B.A. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc. Natl. Acad. Sci. USA 1996; 93: 8745–8749
   PubMed Web of Science ®Google Scholar